InvestorsHub Logo
Followers 7
Posts 301
Boards Moderated 0
Alias Born 03/31/2016

Re: None

Monday, 06/21/2021 7:02:38 AM

Monday, June 21, 2021 7:02:38 AM

Post# of 459492
Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Biomarker Correlated with Efficacy Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome

https://www.globenewswire.com/news-release/2021/06/21/2250100/29248/en/Anavex-Life-Sciences-Announces-ANAVEX-2-73-Blarcamesine-Biomarker-Correlated-with-Efficacy-Endpoints-in-Placebo-Controlled-U-S-Phase-2-Clinical-Trial-for-the-Treatment-of-Adult-Pat.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News